XML 9 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 110,125 $ 26,749
Short-term marketable securities 117,171 60,041
Prepaid expenses and other current assets 3,657 3,385
Total current assets 230,953 90,175
Long-term marketable securities 11,711  
Property and equipment, net 604 684
Operating lease right-of-use assets 2,920 3,078
Restricted cash 1,339 1,339
Other assets 678 659
Total assets 248,205 95,935
Current liabilities:    
Accounts payable 1,918 1,283
Accrued expenses 10,098 7,386
Operating lease liabilities, current 825 837
Total current liabilities 12,841 9,506
Operating lease liabilities 4,520 4,709
Total liabilities 17,361 14,215
Commitments and contingencies (See Note 8)
Stockholders’ equity:    
Common stock, $0.001 par value per share; 115,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 63,800,017 and 43,909,069 shares issued and outstanding as of March 31, 2024 and December 31, 2023 64 43
Additional paid-in capital 434,013 270,150
Accumulated deficit (203,208) (188,554)
Accumulated other comprehensive gain (loss) (25) 81
Total stockholders’ equity 230,844 81,720
Total liabilities and stockholders’ equity $ 248,205 $ 95,935